Search results for "DEXA"

showing 10 items of 264 documents

Hyaluronic Acid-Based Micelles as Ocular Platform to Modulate the Loading, Release, and Corneal Permeation of Corticosteroids

2017

The aim of this work is to prepare hyaluronic acid-based micelles as a platform to load corticosteroid drugs and to improve their corneal permeation after administration on the ocular surface. Three amphiphilic derivatives of hyaluronic acid (HA) are synthesized using different amounts of hexadecylamine (C16 -NH2 ). HAC16 a, HAC16 b, and HAC16 c derivatives are able to form micelles by the cosolvent evaporation method and to entrap corticosteroids (dexamethasone, triamcinolone, triamcinolone acetonide). HAC16 a and HAC16 b micelles show the best results in terms of drug loading and particle size. They are also able to improve drug release compared to free drug solution or suspension. In add…

Materials Chemistry2506 Metals and AlloysTriamcinolone acetonidePolymers and PlasticsAdministration Ophthalmic02 engineering and technologyTriamcinolone01 natural sciencesMicelleDexamethasoneCorneachemistry.chemical_compoundDrug Delivery SystemsAdrenal Cortex HormonesHyaluronic acidMaterials ChemistryCorticosteroidAminesCells CulturedMicellesDrug CarriersChemistryPermeation021001 nanoscience & nanotechnology0210 nano-technologyDrug carriermedicine.drugBiotechnologyTranscorneal enhancerHyaluronic acidBioengineering010402 general chemistryPermeabilityBiomaterialsPolymeric micelleAmphiphilemedicineMucoadhesionAnimalsHumansGlucocorticoidsPolymers and PlasticOcular administrationBiomaterialHydrocarbons0104 chemical sciencesDrug LiberationSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoBiophysicsCattleEx vivo
researchProduct

Spray-Drying, Solvent-Casting and Freeze-Drying Techniques: a Comparative Study on their Suitability for the Enhancement of Drug Dissolution Rates.

2019

Purpose Solid dispersions (SDs) represent the most common formulation technique used to increase the dissolution rate of a drug. In this work, the three most common methods used to prepare SDs, namely spray-drying, solvent-casting and freezedrying, have been compared in order to investigate their effect on increasing drug dissolution rate. Methods Three formulation strategies were used to prepare a polymer mixture of polyvinyl-alcohol (PVA) and maltodextrin (MDX) as SDs loaded with the following three model drugs, all of which possess a poor solubility: Olanzapine, Dexamethasone, and Triamcinolone acetonide. The SDs obtained were analysed and compared in terms of drug particle size, drug-lo…

Materials scienceDrug Compoundingdissolution rate . freeze-drying . solid dispersion . solvent-casting method . spray-dryingPharmaceutical Science02 engineering and technology030226 pharmacology & pharmacyTriamcinolone AcetonideDexamethasoneExcipients03 medical and health sciencesFreeze-dryingchemistry.chemical_compound0302 clinical medicinePolysaccharidesPharmacology (medical)Dissolution testingSolubilityDesiccationDissolutionPharmacologyOrganic Chemistry021001 nanoscience & nanotechnologyMaltodextrinSolventDrug LiberationFreeze DryingChemical engineeringchemistryPharmaceutical PreparationsSolubilityOlanzapineSpray dryingPolyvinyl AlcoholSolventsMolecular MedicineParticle size0210 nano-technologyBiotechnologyPharmaceutical research
researchProduct

Development and In Vitro Evaluation of Lyotropic Liquid Crystals for the Controlled Release of Dexamethasone.

2017

Made available in DSpace on 2018-12-11T17:33:26Z (GMT). No. of bitstreams: 0 Previous issue date: 2017-08-02 Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) In this study, amphiphilic polymers were investigated as biomaterials that can control dexamethasone (DXM) release. Such materials present interfacial properties in the presence of water and an oily phase that can result in lyotropic liquid crystalline systems (LLCS). In addition, they can form colloidal nanostructures similar to those in living organisms, such as bilayers and hexagonal and cubic phases, which can be exploited to solubilize lipophilic drugs to sustain their release and enhance bioavailability. It was…

Materials sciencePolymers and PlasticsAmphiphilic polymersdexamethasone02 engineering and technology030226 pharmacology & pharmacyArticleDexamethasonelcsh:QD241-44103 medical and health scienceschemistry.chemical_compound0302 clinical medicinelcsh:Organic chemistryLyotropicControlled releaseNanostructured systemsLamellar structurelyotropic liquid crystalsIsopropyl myristatedrug releasechemistry.chemical_classificationPolarized light microscopyChromatographySmall-angle X-ray scatteringfungiDrug releaseGeneral ChemistryPolymerkinetic modelKinetic modelamphiphilic polymers; lyotropic liquid crystals; controlled release; drug release; kinetic model; dexamethasone; nanostructured systems021001 nanoscience & nanotechnologyControlled releaseLyotropic liquid crystalschemistryChemical engineeringnanostructured systemsLyotropic liquid crystal0210 nano-technologycontrolled releaseamphiphilic polymersPolymers
researchProduct

Caged Dexamethasone/Quercetin Nanoparticles, Formed of the Morphogenetic Active Inorganic Polyphosphate, are Strong Inducers of MUC5AC

2021

Inorganic polyphosphate (polyP) is a widely distributed polymer found from bacteria to animals, including marine species. This polymer exhibits morphogenetic as well as antiviral activity and releases metabolic energy after enzymatic hydrolysis also in human cells. In the pathogenesis of the coronavirus disease 2019 (COVID-19), the platelets are at the frontline of this syndrome. Platelets release a set of molecules, among them polyP. In addition, the production of airway mucus, the first line of body defense, is impaired in those patients. Therefore, in this study, amorphous nanoparticles of the magnesium salt of polyP (Mg-polyP-NP), matching the size of the coronavirus SARS-CoV-2, were pr…

MetaboliteAnti-Inflammatory AgentsPharmaceutical SciencedexamethasoneMucin 5ACArticleAntioxidantsquercetin03 medical and health scienceschemistry.chemical_compound0302 clinical medicinemucinPolyphosphateshuman alveolar basal epithelial A549 cellsDrug DiscoveryHumansMagnesiumParticle Sizelcsh:QH301-705.5Pharmacology Toxicology and Pharmaceutics (miscellaneous)030304 developmental biologychemistry.chemical_classificationA549 cell0303 health sciencesReactive oxygen speciesSARS-CoV-2PolyphosphateMucinMucinsCOVID-19polyphosphateFree Radical ScavengersPlantsMucusATPlcsh:Biology (General)Gene Expression RegulationchemistryBiochemistryA549 Cells030220 oncology & carcinogenesisRespiratory epitheliumnanoparticlesReactive Oxygen SpeciesQuercetinMarine Drugs
researchProduct

Anthropometric and pharmacotherapeutic variables on acute emesis induced by cisplatin-containing chemotherapy.

2000

OBJECTIVE: To characterize the effects of anthropometric and pharmacotherapeutic variables on acute emesis induced by cisplatin-containing regimens with dosages ·50 mg·m−2. METHODS: A prospective, cross-sectional, noncontrolled study was performed to analyze acute vomiting during the first 24 hours in patients treated in a Spanish hospital. The patients received an intravenous combination of drugs (2 doses of metoclopramide 3 mg/kg, dexamethasone 20 mg) as first-choice antiemetic therapy. Intravenous ondansetron 8 mg and dexamethasone 20 mg served as an alternative regimen in patients <30 years old with a history of extrapyramidal manifestations or emesis in previous cycles. Therapeutic …

Metoclopramidemedicine.drug_classChlorpromazineMetoclopramideVomitingmedicine.medical_treatmentAntineoplastic Agents030204 cardiovascular system & hematology030226 pharmacology & pharmacyDexamethasoneOndansetron03 medical and health sciences0302 clinical medicineSex FactorsOrphenadrinemedicineAntiemeticHumansPharmacology (medical)Body Weights and MeasuresProspective StudiesDexamethasoneChemotherapybusiness.industryAge FactorsMiddle AgedPrognosisOndansetronRegimenDrug CombinationsCross-Sectional StudiesLogistic ModelsAnesthesiaAcute DiseaseMultivariate AnalysisVomitingCorticosteroidAntiemeticsmedicine.symptomCisplatinbusinessmedicine.drugThe Annals of pharmacotherapy
researchProduct

Suppression of inflammation by low-dose methotrexate is mediated by adenosine A2A receptor but not A3 receptor activation in thioglycollate-induced p…

2005

Prior studies demonstrate that adenosine, acting at one or more of its receptors, mediates the anti-inflammatory effects of methotrexate in animal models of both acute and chronic inflammation. Both adenosine A2A and A3 receptors contribute to the anti-inflammatory effects of methotrexate treatment in the air pouch model of inflammation, and the regulation of inflammation by these two receptors differs at the cellular level. Because different factors may regulate inflammation at different sites we examined the effect of low-dose weekly methotrexate treatment (0.75 mg/kg/week) in a model of acute peritoneal inflammation in adenosine A2A receptor knockout mice and A3 receptor knockout mice an…

Mice KnockoutAdenosineDose-Response Relationship DrugReceptor Adenosine A2AReceptor Adenosine A3Anti-Inflammatory AgentsExudates and TransudatesPeritonitisDexamethasoneInterleukin-10MiceMethotrexateThioglycolatesAnimalsPeritoneumGlucocorticoidsResearch ArticleArthritis researchtherapy
researchProduct

Microscopic Study of Injectable Steroids: Effects of Postmixing Time on Particle Aggregation

2020

Background: Epidural steroid injection (ESI) is a common practice for pain treatment since 1953. In 2014, the FDA issued a warning about ESI. Studies have focused on the effect of the particle size and their ability to generate harmful aggregates. Although steroid aggregates provide longer times for reabsorption, therefore a longer anti-inflammatory effect, they are potentially harmful to the central nervous system via embolic mechanisms. Previous studies have established that steroidal aggregates with asizes over 100 μm are potentially able to occlude blood vessels. Studies by Tiso et al and Benzon et al addressed the role of steroids on CNS adverse events, with similar outcomes. The main …

MicroscopyR softwareTriamcinolone acetonidebusiness.industryEpidural steroid injectionmedicine.medical_treatmentInjections EpiduralPharmacologyTriamcinoloneBetamethasoneDexamethasoneSteroidParticle aggregationAnesthesiology and Pain MedicineHumansMedicineBetamethasoneSteroidsParticle sizeParticle SizebusinessGlucocorticoidsDexamethasonemedicine.drugPain Physician
researchProduct

Lisdexamfetamine in the treatment of moderate-to-severe binge eating disorder in adults: systematic review and exploratory meta-analysis of publicly …

2016

Michele Fornaro,1,2 Marco Solmi,3–5 Giampaolo Perna,2,6 Domenico De Berardis,2,7 Nicola Veronese,5,8 Laura Orsolini,2,9 Licinia Ganança,1,10 Brendon Stubbs11,12 1New York State Psychiatric Institute, Columbia University, New York City, NY, USA; 2Polyedra Research Group®, Ascoli, 3Department of Neurosciences, University of Padua, 4Department of Mental Health, National Health Service, Padova, 5IREM Institute for Clinical Research and Education in Medicine, Padova, 6Department of Clinical Neurosciences, Hermanas Hospitalarias – Villa San Benedetto Menni Hospital, FoRiPsi, Albese con Cassano, Como, 7Department of Mental Health, Psychiatric Service of Diagn…

Moderate to severemedicine.medical_specialtyNeuropsychiatric Disease and TreatmentNeurosciences. Biological psychiatry. Neuropsychiatrymeta-analysis.Placebolisdexamfetaminemeta-analysilaw.inventionFood and drug administration03 medical and health sciencessystematic-review0302 clinical medicineRandomized controlled trialsystematic reviewBinge-eating disorderlawmedicinebinge eating disorderlisdexamfetamine binge eating disorder systematic review meta-analysisPsychiatryRC346-429Original Researchbusiness.industrydigestive oral and skin physiologymedicine.disease030227 psychiatrymeta-analysisLisdexamfetamineMeta-analysisbinge eating disorder; lisdexamfetamine; meta-analysis; systematic reviewNeurology. Diseases of the nervous systembusiness030217 neurology & neurosurgerymedicine.drugRC321-571Neuropsychiatric disease and treatment
researchProduct

The efficacy of etodolac and ibuprofen, regarding gender, on pain, edema and trismus after impacted lower third molar surgery:a randomized prospectiv…

2020

Made available in DSpace on 2021-06-25T10:54:54Z (GMT). No. of bitstreams: 0 Previous issue date: 2021-01-01 Background: This study aimed to conduct a randomized prospective study about the efficacy of etodolac and ibuprofen on trismus, pain and edema regarding gender of patients submitted to impacted lower third molar teeth extraction. Material and Methods: Thirty patients aging between 16 and 35 year-old were submitted to the exodontia of impacted lower third molars. During the postoperative period, patients received nine ibuprofen (600 mg) or etodolac (300 mg) pills via oral administration immediately after surgery and repeated doses every eight hours during three days. Patients were eva…

MolarAdultMaleAdolescentTooth extractionDentistryketorolacIbuprofendexamethasoneTrismusanti-inflammatory agentsYoung AdultOral administrationThird; sexEdemamedicineEdemaHumansProspective Studiesthird molarEtodolacProspective cohort studyGeneral DentistryUNESCO:CIENCIAS MÉDICASMouthPain Postoperativebusiness.industryResearchTooth ImpactedIbuprofenMolarOtorhinolaryngologyPillTooth ExtractionEtodolacSurgeryFemaleMolar ThirdTrismusmedicine.symptomOral Surgerybusinessmedicine.drug
researchProduct

Effects of zoledronic acid and dexamethasone on early phases of socket healing after tooth extraction in rats : a preliminary macroscopic and microsc…

2018

Background The exact pathogenesis of medication-related osteonecrosis of the jaw (MRONJ) is still unknown. The aim of this paper was to investigate the effects of zoledronic acid and dexamethasone on the early phases of socket healing in rats subjected to tooth extractions. Material and Methods Thirty male Sprague-Dawley rats were divided into 2 groups: pharmacologically treated group (T, n=20) and non-pharmacologically treated group (C, n=10). T group rats received 0.1 mg/Kg of zoledronic acid (ZOL) and 1 mg/Kg of dexamethasone (DEX) three times a week for 10 consecutive weeks. C group rats were infused with vehicle. After 9 weeks from the first infusion, first maxillary molars were extrac…

MolarMalemedicine.medical_specialtyConnective tissueZoledronic AcidDexamethasoneBone remodelingRats Sprague-Dawley03 medical and health sciences0302 clinical medicineOsteoclastInternal medicinemedicineAnimalsHumansTooth SocketGeneral DentistryDexamethasoneDental alveolusOral Medicine and PathologyBone Density Conservation AgentsDiphosphonatesbusiness.industryResearchOsteonecrosis030206 dentistrymedicine.disease:CIENCIAS MÉDICAS [UNESCO]Ratsmedicine.anatomical_structureZoledronic acidEndocrinologyOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASTooth ExtractionSurgerybusinessOsteonecrosis of the jawmedicine.drug
researchProduct